The Procter & Gamble (PG) news

P&G: Bernstein raises target price to $149 from $148

Bernstein SocGen Group has adjusted its price target for Procter & Gamble Co. (NYSE:PG), raising it to $149 from $148, while maintaining a Market Perform rating. The firm cited the company’s low single-digit organic sales growth, driven by its Beauty segment, as a key factor in the revised outlook.…

Diageo: Most recently, Keith served as CEO of Procter & Gamble's beauty business

P&G: Argus Research cuts to hold from buy

Argus Research has downgraded its recommendation for Procter & Gamble (NYSE: PG) from "Buy" to "Hold," citing evolving market dynamics and a reassessment of the company’s near-term growth prospects. The move reflects a broader recalibration of expectations for the consumer goods giant, particularly…

P&G Health 1Q net income 961.5M rupees, +45% y/y

Procter & Gamble (P&G) reported strong financial performance for fiscal year 2023, with organic sales growth of 7% and core EPS increasing by 2% despite significant cost pressures. The company's Health segment, which includes Personal Health Care and Oral Care, demonstrated robust growth, with…

L Catterson confirms Thorne sale to P&G for $3.8B

Procter & Gamble has confirmed the acquisition of Thorne, a vertically integrated supplement brand, from L Catterton for $3.8 billion, according to statements from P&G CEO Shailesh Jejurikar on CNBC's "Squawk on the Street" . L Catterton had acquired Thorne in 2023 for $680 million, and the brand…